CHRNA5/CHRNA3 polymorphisms and tobacco smoking risk in a Brazilian population sample

de Lima Mota Caroline; Mitri Simone; Barata-Silva  Cristiane; Costa Moreira Josino

doi:10.30574/gscbps.2020.12.2.0253

Authors

de Lima Mota Caroline Department of Toxicogenetics, Center for Studies of Worker’s Health and Human Ecology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mitri Simone Department of Toxicogenetics, Center for Studies of Worker’s Health and Human Ecology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Barata-Silva Cristiane Department of Chemistry, Inorganic Contaminants Section, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Costa Moreira Josino Department of Toxicogenetics, Center for Studies of Worker’s Health and Human Ecology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

DOI:

https://doi.org/10.30574/gscbps.2020.12.2.0253

Keywords:

Tobacco smoking, Public health, Nicotinic receptors, Genetic polymorphism, CHRNA polymorphisms, Smoking behavior.

Abstract

Tobacco smoking is a major risk factor of several diseases such as lung cancer, stroke, chronic obstructive pulmonary disease and increases the susceptibility to infectious diseases. The understanding of smoking addiction requires phenotyping and genotyping studies. Variations in CHRNA5/CHRNA3 can alter receptor responses to nicotine and thus interfere with smoking behavior and risk. Therefore, this study aimed to investigate the association of CHRNA5 rs16969968 and CHRNA3 rs578776 with smoking behavior in a Brazilian population sample, comprising 449 subjects. Smoking data was obtained from a questionnaire. The polymorphisms were genotyped by Polymerase Chain Reaction (PCR). Associations were verified using logistic and linear regression analyses. We found that women with the variant AA genotype for CHRNA5 rs16969968 were at significantly increased risk of smoking, with an OR of 3.09 (95% CI: 1.09-8.76; p= 0.033). The variant TT genotype of CHRNA3 rs578776 showed protection against smoking and later smoking initiation in the overall population and in women, with an OR of 0.41 (95% CI: 0.19-0.88; p=0.022). In conclusion, CHRNA5 rs16969968 and CHRNA3 rs578776 were associated with increased risk and protective effect against smoking, respectively, in a Brazilian population sample. Gender and recessive homozygosis of the polymorphisms variants resulted in a significant effect regarding the results.

Metrics

Metrics Loading ...

References

World Health Organization. (WHO). (2019).Who report on the global tobacco epidemic 2019: Offer Help to Quit Tobacco Use. World Health Organization, Geneva, 18-19.

National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (NCCDPHP). (2014). The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention, Atlanta, 1-7.

Benowitz NL. (2010). Nicotine addiction. The New England Journal of Medicine, 362(24), 2295-2303.

Nestler EJ. (2005). Is there a common molecular pathway for addiction? Nature Neuroscience, 8(11), 1445-1449.

Improgo MRD, Scofield MD, Tapper AR and Gardner PD. (2010). From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene, 29(35), 4874-4884.

Schmidt HD, Rupprecht LE and Addy NA. (2018). Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse. Molecular Neuropsychiatry, 4(4), 169-189.

LI MD. (2018). Involvement of Variants in Gene Clusters CHRNA5/A3/B4 on Chromosome 15 to Smoking Behaviors and Lung Cancer. In: Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment. Springer, Singapore, 47-69.

Yang J and Li MD. (2016). Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. Molecular Psychiatry, 21(8), 992-1008.

Lips EH; Gaborieau V, McKay JD, Chabrier A, Hung RJ, Boffetta P, Hashibe M, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Field JK, Liloglou T, Xinarianos G, McLaughlin J, Liu G, Skorpen F, Elvestad MB, Hveem K, Vatten L, Study E, Benhamou S, Lagiou P, Holcátová I, Merletti F, Kjaerheim K, Agudo A, Castellsagué X, Macfarlane TV, Barzan L, Canova C, Lowry R, Conway DI, Znaor A, Healy C, Curado MP, Koifman S, Eluf-Neto J, Matos E, Menezes A, Fernandez L, Metspalu A, Heath S, Lathrop M and Brennan P. (2010). Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. International Journal of Epidemiology, 39(2), 563-577.

Sieminska A, Jassem E and Kita-Milczarska K. (2015). Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey. BMC Public Health, 15(1), 80.

Conlon MS and Bewick MA. (2011). Single Nucleotide Polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 Are Associated with Heaviness of Smoking in Women in Northeastern Ontario, Canada. Nicotine and Tobacco Research, 13(11), 1076-1083.

Zhu AZX, Renner CC, Hatsukami DK, Benowitz NL and Tyndale RF. (2013). CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users: CHRNA5-A3-B4 in Alaska Native people. Addiction, 108(10), 1818-1828.

Buczkowski K, Sieminska A, Linkowska K, Czachowski S, Przybylski G, Jassem E and Grzybowski T. (2015). Association between Genetic Variants on Chromosome 15q25 Locus and Several Nicotine Dependence Traits in Polish Population: A Case-Control Study. BioMed Research International, 350348.

Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR and Leppert MF. (2008). A Candidate Gene Approach Identifies the CHRNA5-A3-B4 Region as a Risk Factor for Age-Dependent Nicotine Addiction. PLoS Genetics, 4(7), e1000125.

Erlich PM, Hoffman SN, Rukstalis M, Han JJ, Chu X, Linda Kao WH, Gerhard GS, Stewart WF and Boscarino JA. (2010). Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity. Human Gene, 128(50, 491-499.

Belsky DW, Moffitt TE, Baker TB, Biddle AK, Evans JP, Harrington H, houts R, Meier M, Sugden K, Williams B, Poulton R and Caspi A. (2013). Polygenic Risk and the Developmental Progression to Heavy, Persistent Smoking and Nicotine Dependence: Evidence From a 4-Decade Longitudinal Study. JAMA Psychiatry, 70(5), 534-542.

Chuang Y-H, Paul KC, Sinsheimer JS, Bronstein JM, Bordelon YM and Ritz B. (2019). Genetic variants in nicotinic receptors and smoking cessation in Parkinson’s disease. Parkinsonism & Related Disorders, 62, 57-61.

Wang Q, Li S, Pan L, Li H, Yang X, Jiang F, Zhang N and Han M and Jia C. (2016). Association between variants in nicotinic acetylcholine receptor genes and smoking cessation in a Chinese rural population: Association of Genes with Smoking Cessation. The American Journal on Addictions, 25(4), 297-300.

Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M, Yeager M, Jacobs K, Landi MT, Ziegler RG, Chanok S, Kraft P, Bergen AW, Chen C, Wheeler W, Hunter DJ and Hankinson SE. (2009). Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors. PLoS ONE, 4(2), e4653.

Stevens VL, Bierut LJ, Talbot JT, Wang JC, Sun J, Hinrichs AL, Thun MJ, Goate A and Calle EE. (2008). Nicotinic Receptor Gene Variants Influence Susceptibility to Heavy Smoking. Cancer Epidemiology, Biomarkers & Prevention, 17(12), 3517-3525.

Pérez-Rubio G, Córdoba-Lanús E, Cupertino P, Cartujano-Barrera F, Campos MA and Falfán-Valencia R. (2019). Role of Genetic Susceptibility in Nicotine Addiction and Chronic Obstructive Pulmonary Disease. Revista de Investigação Clinica, 71(1), 36-54.

Tomaz PRX, Santos JR, Scholz J, Abe TO, Gaya PV, Negrão AB, Kreger JE, Pereira AC and Santos PCJL. (2018). Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. Molecular Genetics & Genomic Medicine, 19(1), 55.

Silva MR, Gattás GJF, Antonio J, Firigato I, Curioni OA and Gonçalves F de T. Polymorphisms of CHRNA3 and CHRNA5: Head and neck cancer and cigarette consumption intensity in a Brazilian population. Molecular Genetics & Genomic Medicine, 7(12), e998.

Brazil. Ministry of Health, Secretariat of Health Surveillance, Department of Health Analysis and Surveillance of Noncommunicable Diseases. (2020). Vigitel Brasil 2019: vigilância de fatores e risco e proteção para doenças crônicas por inquérito telefônico. Ministério da Saúde, Brasília, 27-36.

Pinto M, Bardac A, Palacios A, Bin A, Alcaraz A, Rodríguez B and Augustovski F e Pichon-Riviere A. (2017). Carga de doença atribuível ao uso do tabaco no Brasil e potencial impacto do aumento de preços por meio de impostos. INCA - Instituto Nacional de Câncer. Documento técnico IECS N° 21. Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, 19-22.

Sales MPU, Araújo AJ de, Chatkin JM, Godoy I, Pereira LFF, Castellano MVC de O, Tanni SE, Almeida AA, Chatkin G, Silva LCC, Gonçalves CMC, Botelho C, Santos UP, Viegas CA de A, Sestelon MR, Meireles RHA, Correa PCRP, Oliveira MEM, Reichert J, Lima MS and Silva CAR. (2019). Update on the approach to smoking in patients with respiratory diseases. Jornal Brasileiro de Pneumologia, 45(3), e20180314.

Robinson JD, Versace F, Lam CY, Minnix JA, Engelmann JM, Cui Y, Karam-Hage M, Shete SS, Tomlinson GE, Chen TTL, David WW, Charles EG and Cincipirini PM. (2013). The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers. Frontiers in Psychiatry, 4, 114.

Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, Saccone N, Saccone SF, Bertelsen S, Fox L, Horton WL, Breslau N, Budde J, Cloninger CR, Dick DM, Foround T, Hatsukami D, Hesselbrock V. Johnson EO, Karmer J, Kuperman S, Madden PAF, Mayo K, Nurnberger J, Pomerleau O, Porjesz B, Reyes O, Schuckit M, Swan G, Tischfield JA, Edenberg HJ, Rice JP and Goate AM. (2008). Variants in Nicotinic Receptors and Risk for Nicotine Dependence. American Journal of Psychiatry, 165(9), 1163-1171.

Bierut LJ. (2009). Nicotine dependence and genetic variation in the nicotinic receptors. Drug and Alcohol Dependence, 104 (Suppl 1), S64-69.

Lins TC, Vieira RG, Abreu BS, Grattapaglia D and Pereira RW. (2009). Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. American Journal of Human Biology, 22(2), 187-192.

Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF, Grucza RA, Sun L, Duan W, Budde J, Culverhouse RC, Fox L, Hinrichs AL, Steinbach JH, Wu M, Rice JP, Goate AM and Bierut LJ. (2009). The CHRNA5-CHRNA3-CHRNB4 Nicotinic Receptor Subunit Gene Cluster Affects Risk for Nicotine Dependence in African-Americans and in European-Americans. Cancer Research, 69(17), 6848-6856.

Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PAF, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP and Bierut LJ. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics, 16(1), 36-49.

Hubacek JA, Pankova A, Stepankova L, Zvolska K, Adamkova V, Lanska V and Kralikova E. (2017). SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population. Gene, 606, 35-38.

Smith PH, Bessette AJ, Weinberger AH, Sheffer CE and McKee SA. (2016). Sex/gender differences in smoking cessation: A review. Preventive Medicine, 92, 135-140.

Petersen N and London ED. (2018). Addiction and dopamine: sex differences and insights from studies of smoking. Current Opinion in Behavioral Sciences, 23, 150-159.

Park SJ, Yi B, Lee HS, Oh WY, Na HK, Lee M and Yang M. (2016). To quit or not: Vulnerability of women to smoking tobacco. Journal of Environmental Science and Health, Part C, 34(1), 33-56.

Rodriguez S, Cook DG, Gaunt TR, Nightingale CM, Whincup PH and Day IN. (2011). Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. Journal of Psychopharmacology, 25(7), 915-923.

Grucza RA, Wang JC, Stitzel JA, Hinrichs AL, Saccone SF, Saccone NL, Bucholz K, Cloninger CR, Neuman RJ, Budde JP, Fox L, Bertelsen S, Kramer J, Hesselbrock V, Tischfielld J, Nurberger JI, Almasy L, Porjesz B, Kuperman S, Schuckit MA, Edenberg HJ, Rice JP, Goat AM and Bierut LJ. (2008). A Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence. Biological Psychiatry, 64(11), 922-929.